Teva stock advanced early Tuesday on better-than-expected third-quarter metrics and a raised outlook for 2026. The post Teva Pharma Jumps As Top 6% Pharma Raises Outlook After Quarterly Beat appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real